Micheli F, Cugola A, Donati D, Missio A, Pecunioso A, Reggiani A, Tarzia G
GlaxoWellcome S.p.A., Medicines Research Center, Verona, Italy.
Bioorg Med Chem. 1997 Dec;5(12):2129-32. doi: 10.1016/s0968-0896(97)00156-9.
2,3-Dihydro-6,7-dichloro-pyrido[2,3-b]pyrazine-8-oxide was synthesized and evaluated for in vitro/in vivo antagonistic activity at the strychnine insensitive glycine binding site on the NMDA receptor revealing it to be a useful tool to evaluate the effectiveness of glycine antagonists in vivo.
合成了2,3 - 二氢 - 6,7 - 二氯 - 吡啶并[2,3 - b]吡嗪 - 8 - 氧化物,并对其在NMDA受体上士的宁不敏感甘氨酸结合位点的体外/体内拮抗活性进行了评估,结果表明它是评估甘氨酸拮抗剂体内有效性的有用工具。